HOME >> BIOLOGY >> NEWS
'Mimics' may open screen(ing) door to GPCR drugs

ROCKVILLE, Md.- For starters, a team of scientists at the University of Maryland Biotechnology Institute and partners have engineered "soluble mimics" of rhodopsin, the light-sensing protein that lies deeply embedded in membranes of retina cells of the eye. Next, these mimics may open the door for drug designers to use x-rays, nuclear magnetic resonance (NMR), and other high-resolution structural tools to study the detailed workings of rhodopsin and other members of the superfamily of membrane proteins called G-protein coupled receptors (GPCRs).

In the journal Biochemistry, Kevin D. Ridge and co-authors describe a new approach for structurally characterizing functional regions of the rhodopsin protein that reside outside of the membrane. Assembly of these regions mimics how the receptor interacts with binding molecules called G-proteins. Ridge is a research chemist with UMBI's Center for Advanced Research in Biotechnology (CARB) and the National Institute of Standards and Technology (NIST).

GPCRs are very important to human health because they transmit and transform chemical signals from outside of cell to G-proteins inside the cell that mediate vision, smell, hearing, taste, and other processes. The GPCRs are already the targets of many therapeutic drugs for allergy, pain, hypertension, and other medical conditions.

GPCRs have been notoriously difficult to study at the structural level. They cross through the cell membrane seven times and any fault or mutation in the serpentine-like receptors may lead to a disease or illness. Ridge says engineering soluble mimics of these receptors may help medical researchers discover new drugs that target some of the consequences of these mutations.

Specifically, designing and characterizing "soluble mimics" of GPCRs could benefit structural approaches that are aimed at discovering more rationally designed drugs, possibly with fewer side effects, that could "block a mal
'"/>

Contact: Steve Berberich
berberic@umbi.umd.edu
301-990-4804
University of Maryland Biotechnology Institute
24-Jun-2003


Page: 1 2

Related biology news :

1. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
2. New and better drugs for tuberculosis goal of UH professor
3. New technique helps scientists reveal interactions between genes and drugs
4. New database to help develop AIDS drugs
5. Orange, tangerine peels could be better than drugs for lowering cholesterol
6. New papillomavirus target could lead to specific antiviral drugs for precancerous cervical lesions
7. Newer drugs more effective at curing strep throat than penicillin
8. New software developed at Rensselaer predicts promising ingredients for new drugs
9. Protein abundant in human tumors confers resistance to anticancer drugs
10. Findings could aid efforts to harness nature for making drugs
11. New way to lock DNA-slicing enzyme onto chromosomes could lead to novel anti-cancer drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2018)... ... August 13, 2018 , ... NRD, LLC – NRD® is ... Ionizing Gun. , The ionizing gun features ergonomic design and rugged construction. ... filter and electropolished OSHA-compliant tip. This can be cleanroom packaged (P-2021-5502) or normally ...
(Date:8/14/2018)... ... August 14, 2018 , ... From ... movie “Wonder,” to a better understanding of congenital heart defects, 3-D printing is ... the latest special issue of Birth Defects Research (DOI: 10.1002/bdr2.1367). ...
(Date:8/7/2018)... ... 06, 2018 , ... Nurse practitioners and ... their healthcare careers in the past year, according to the second annual survey ... jobseekers with a wide variety of career- and employment-related resources including physician/candidate database, ...
Breaking Biology News(10 mins):
(Date:7/24/2018)... ... ... R3 Stem Cell is now offering regenerative therapies for COPD lung disease ... Certified providers, with outcomes significantly improving patient quality of life. , Traditional therapies for ... help repair and regenerate damaged lung tissues. Stem cell therapy for COPD ...
(Date:7/24/2018)... ... 24, 2018 , ... On August 6, 2018, BioMedGPS will ... Not just a pretty face, SmartTRAK 3.0’s latest improvements were inspired by its ... world’s first online and real-time data portal that specializes in providing competitive market ...
(Date:7/22/2018)... ... July 19, 2018 , ... Mitotech ... with Essex Bio-Investment for Phase 3 clinical program in Dry Eye Disease. Under ... SkQ1 with approximately $17m allocated towards the first Phase 3 study starting as ...
(Date:7/22/2018)... ... July 20, 2018 , ... ... automation and IT solutions with 150 employees on both the east and west ... Program. Superior Controls met the high criteria for application expertise, operational excellence ...
Breaking Biology Technology:
Cached News: